CIDP will be presenting Clinical Research in Mauritius: myths and reality. The aim of this presentation is to bring light on the advantages of conducting trials in Mauritius and clarify myths and reality about clinical research in this country.

Indeed, the island has a multi-ethnic population with sizeable and representative samples of Chinese, Indian, African ethnic population with the same genetic traits. Mauritius is at an advanced stage in its epidemiological transition; whilst communicable diseases and neo-nativity problems have diminished and are controlled effectively, non-communicable diseases are climbing. For example, with 20.5% of the population diagnosed with diabetes in 2015, Mauritius is an interesting source of potential participants in diabetes-related clinical trials. (The prevalence of type 2 diabetes in the Mauritian population aged 20-74 years was 20.5%: 19.6% in men and 21.3% in women)

More epidemiological and interventional studies are needed to better understand health issues in Mauritius and develop effective treatments for this population. However, some investors may be reluctant to do so, because of the substantial ethical debate of conducting clinical research in developing countries, and fear that the quality and training of investigators and staff do not meet international standards.

About the conference:

The 3rd International Conference on Advanced Clinical Research and Clinical Trials includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

Clinical Research 2017 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances.

Clinical Research 2017 will discuss various disciplines involved in the pre-clinical research, conduct of clinical trials; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials. It promotes better understanding by the general public about the importance of clinical trials in prevention, diagnosis and treatment of disease.